
Jake Minh Vu
Examiner (ID: 14384, Phone: (571)272-8148 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1094 |
| Issued Applications | 353 |
| Pending Applications | 146 |
| Abandoned Applications | 625 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17593611
[patent_doc_number] => 20220143184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => MITOCHONDRION/RIBONUCLEIC ACID-TARGETED AND MIGRATABLE PHOTOSENSITIZED PROBE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/435268
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435268
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435268 | MITOCHONDRION/RIBONUCLEIC ACID-TARGETED AND MIGRATABLE PHOTOSENSITIZED PROBE AND APPLICATION THEREOF | Dec 2, 2020 | Pending |
Array
(
[id] => 16961518
[patent_doc_number] => 20210213017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => METHOD OF TREATMENT AND CLINICAL TRIAL DESIGN FOR GEOGRAPHIC ATROPHY DUE TO AGE-RELATED MACULAR DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/103613
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17103613
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/103613 | METHOD OF TREATMENT AND CLINICAL TRIAL DESIGN FOR GEOGRAPHIC ATROPHY DUE TO AGE-RELATED MACULAR DEGENERATION | Nov 23, 2020 | Abandoned |
Array
(
[id] => 16656142
[patent_doc_number] => 20210052778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => FABRICATING A CARBON NANOFIBER YARN NERVE SCAFFOLD
[patent_app_type] => utility
[patent_app_number] => 17/091454
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/091454 | FABRICATING A CARBON NANOFIBER YARN NERVE SCAFFOLD | Nov 5, 2020 | Abandoned |
Array
(
[id] => 16776490
[patent_doc_number] => 20210113567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => MODIFIED RELEASE FORMULATIONS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE
[patent_app_type] => utility
[patent_app_number] => 17/082747
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/082747 | Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile | Oct 27, 2020 | Issued |
Array
(
[id] => 16685916
[patent_doc_number] => 20210068391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => ARTICLES HAVING ANTIMICROBIAL PROPERTIES AND METHODS OF MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/034953
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17034953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/034953 | ARTICLES HAVING ANTIMICROBIAL PROPERTIES AND METHODS OF MANUFACTURING THE SAME | Sep 27, 2020 | Pending |
Array
(
[id] => 16568966
[patent_doc_number] => 20210007972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => Topical treatment for warts using film forming polymers
[patent_app_type] => utility
[patent_app_number] => 17/032519
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032519
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/032519 | Topical treatment for warts using film forming polymers | Sep 24, 2020 | Abandoned |
Array
(
[id] => 16539343
[patent_doc_number] => 20200405756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => COMPOSITIONS AND THERAPIES USING NANODIAMONDS SUSPENDED IN A CARRIER
[patent_app_type] => utility
[patent_app_number] => 17/012649
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012649
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012649 | COMPOSITIONS AND THERAPIES USING NANODIAMONDS SUSPENDED IN A CARRIER | Sep 3, 2020 | Abandoned |
Array
(
[id] => 16482475
[patent_doc_number] => 20200376075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => Oil-free and fat-free aqueous suspensions of cyclosporin
[patent_app_type] => utility
[patent_app_number] => 16/996794
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996794
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996794 | Oil-free and fat-free aqueous suspensions of cyclosporin | Aug 17, 2020 | Abandoned |
Array
(
[id] => 17928416
[patent_doc_number] => 20220323541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => ORTHOPOXVIRUS MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I LIKE PROTEIN (OMCP) FOR TREATMENT OF AUTOIMMUNE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/634764
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634764 | ORTHOPOXVIRUS MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I LIKE PROTEIN (OMCP) FOR TREATMENT OF AUTOIMMUNE DISEASE | Aug 12, 2020 | Abandoned |
Array
(
[id] => 17838111
[patent_doc_number] => 20220275416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PERIVASCULAR LYSATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/632568
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -86
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632568
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632568 | PERIVASCULAR LYSATES AND USES THEREOF | Aug 6, 2020 | Abandoned |
Array
(
[id] => 16419815
[patent_doc_number] => 20200345013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => ANTI-ADHERENT BOTANICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/935617
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16935617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/935617 | ANTI-ADHERENT BOTANICAL COMPOSITIONS | Jul 21, 2020 | Abandoned |
Array
(
[id] => 17836263
[patent_doc_number] => 20220273568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXMEDETOMIDINE
[patent_app_type] => utility
[patent_app_number] => 17/625705
[patent_app_country] => US
[patent_app_date] => 2020-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625705 | MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXMEDETOMIDINE | Jul 8, 2020 | Pending |
Array
(
[id] => 17895481
[patent_doc_number] => 20220305143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES
[patent_app_type] => utility
[patent_app_number] => 17/616166
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616166 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | May 31, 2020 | Pending |
Array
(
[id] => 17895481
[patent_doc_number] => 20220305143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES
[patent_app_type] => utility
[patent_app_number] => 17/616166
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/616166 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | May 31, 2020 | Pending |
Array
(
[id] => 17256624
[patent_doc_number] => 20210369609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => METHOD FOR LIFTING SUBMUCOSAL OR MUCOSAL TISSUES
[patent_app_type] => utility
[patent_app_number] => 16/888049
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888049
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888049 | METHOD FOR LIFTING SUBMUCOSAL OR MUCOSAL TISSUES | May 28, 2020 | Abandoned |
Array
(
[id] => 17790616
[patent_doc_number] => 20220249707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/612968
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612968
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612968 | NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME | May 18, 2020 | Pending |
Array
(
[id] => 16236648
[patent_doc_number] => 20200253882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => Multiparticulate L-Carnitine Compositions and Related Methods
[patent_app_type] => utility
[patent_app_number] => 16/864715
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864715 | Multiparticulate L-carnitine compositions and related methods | Apr 30, 2020 | Issued |
Array
(
[id] => 16511654
[patent_doc_number] => 20200390911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => LIPID ENCAPSULATED GAS MICROSPHERE COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 16/864136
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864136 | LIPID ENCAPSULATED GAS MICROSPHERE COMPOSITIONS AND RELATED METHODS | Apr 29, 2020 | Pending |
Array
(
[id] => 17702958
[patent_doc_number] => 20220202964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => HEPARANASE COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/605144
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605144
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605144 | HEPARANASE COMPOUNDS AND METHODS OF USE | Apr 22, 2020 | Pending |
Array
(
[id] => 17733112
[patent_doc_number] => 20220218571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => HYDROGEL DRUG DELIVERY COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/604659
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604659 | Hydrogel drug delivery composition | Apr 19, 2020 | Issued |